Although early clinical studies conducted by Linus Pauling showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal cancer ...

Survival outcomes in pancreatic cancer: A single-center retrospective study in a large healthcare system. Impact of palliative care on the management and outcomes of elderly pancreatic cancer patients ...

Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The phase-two clinical trial found that adding high-dose, intravenous vitamin C to ...

It may contain inaccuracies due to the limitations of machine translation. Announced by the National Evidence-based Healthcare Collaborating Agency and the Korea Science Journalists Association The ...

Dr. Joseph Cullen is the lead author on a recently-published University of Iowa study which found that high doses of vitamin C, administered through an IV, increase survival rates and decrease ...

A new study has revealed “groundbreaking” results that may offer hope for pancreatic cancer patients. The common supplement vitamin C was found to have a significant impact for patients in active ...